Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
08/1999
08/04/1999EP0575490B1 GnRH ANALOGS
08/04/1999CN1225015A APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
08/04/1999CN1224725A Somatotropin releasing peptide and its application
08/04/1999CN1044479C Process for preparation of anti-thrombin polypeptides
08/03/1999US5932706 Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
08/03/1999US5932694 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
08/03/1999US5932693 The present invention relates to novel antithrombotic peptides and, more particularly, to short peptides that mediate divalent cation-independent adhesion of platelets to fibronectin.
08/03/1999US5932692 Antigenic peptides
08/03/1999US5932548 Lysine containing peptides for treatment of heart disease
08/03/1999US5932547 Non-aqueous polar aprotic peptide formulations
08/03/1999US5932546 Peptides and compounds that bind to the thrombopoietin receptor
08/03/1999US5932543 Cyclic peptide antifungal agents and process for preparation thereof
08/03/1999US5932476 Cloning of chicken anemia virus DNA
08/03/1999US5932448 Bispecific antibody heterodimers
08/03/1999US5932415 Processes and agents for detecting listerias
08/03/1999US5932189 Radiotherapy, radiodiagnosis peptides
08/03/1999CA2002924C Anti-thrombins
07/1999
07/29/1999WO1999037678A2 Antimicrobial peptides
07/29/1999WO1999037674A1 Secreted proteins and polynucleotides encoding them
07/29/1999WO1999037669A1 PEPTIDES WITH β1 INTEGRIN SUBUNIT DEPENDENT CELL ADHESION MODULATING ACTIVITY
07/29/1999WO1999037664A1 Novel peptides having biological activity
07/29/1999WO1999037279A1 Skin and hair darkening composition
07/29/1999WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
07/29/1999CA2319207A1 Peptides with .beta.1 integrin subunit dependent cell adhesion modulating activity
07/29/1999CA2318514A1 Skin and hair darkening composition
07/29/1999CA2318303A1 Secreted proteins and polynucleotides encoding them
07/28/1999EP0931091A1 Inhibitors of pla 2
07/28/1999EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
07/27/1999US5929223 Nucleotide sequence of drosophila cyclic 3',5'-adenosine monophosphate responsive transcriptional activator and antagonist
07/27/1999US5928938 Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof
07/27/1999US5928928 For diagnosis of infections; for fungicides, antiprotozoa agents, antihelminthic agents; in body lotions, dentrifices, foods; for temporary implants; time-release agents
07/27/1999US5928901 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them
07/27/1999US5928887 κ/μ-Like protein tyrosine phosphatase, PTP λ
07/27/1999US5928876 Peptide and collagen contraction inhibitor
07/27/1999US5928873 Testing extraintestinal tissues or body fluids for presence of heat stable toxin receptor protein, comparing to negative control assay, increased presence indicates metastasis
07/27/1999US5928861 Using specific antibodies against an epitope in the envelope protein gp46 for the detection of human t-cell leukemia virus in humans
07/27/1999CA1340684C Antiherpes pentapeptides
07/27/1999CA1340683C Antiherpes pentapeptides having a substituted aspartic acid side chain
07/27/1999CA1340682C Antiviral peptides having a 2-oxoalkyl amino acid side chain
07/22/1999WO1999036568A2 Method for identifying t-cell stimulating protein fragments
07/22/1999WO1999036437A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
07/22/1999WO1999036081A1 Peptide ligands that bind to surfaces of bacterial spores
07/22/1999WO1999027958A3 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
07/22/1999CA2318284A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
07/21/1999EP0929678A2 Protein and peptide vaccines for inducing mucosal immunity
07/21/1999EP0929574A1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS
07/21/1999EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides
07/21/1999EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders
07/21/1999EP0745092B1 Peptide inhibitors of urokinase receptor activity
07/21/1999CN1223732A Small molecule mimetics of erythropoietin
07/20/1999US5925730 Decapeptide gonadotrophin releasing hormone antagonists; for antifertility agents especially for males; precocious puberty; dysmenorrhea; antitumor/anticarcinogenic agents; endometriosis
07/20/1999US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology
07/20/1999US5925618 Peptides useful as somatostatin antagonists
07/20/1999US5925331 Technetium-99m labeled peptides for thrombus imaging
07/20/1999CA2155001C Htlv-i and htlv-ii gp21 derived peptides for use in diagnostics
07/20/1999CA2053921C Synthetic peptides for an hiv-1 vaccine
07/20/1999CA1340667C Peptides having bradykinin antagonist action
07/20/1999CA1340661C Respriatory synctial virus: vaccines and diagnostic assays
07/20/1999CA1340656C Membrane anchor/active compound conjugate, its preparation and its use
07/15/1999WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability
07/15/1999WO1999035164A1 Anti-cryptococcal peptides
07/15/1999WO1999027366A3 Method of detecting prostate specific antigen activation peptide
07/15/1999CA2351624A1 Compounds and methods for modulating tissue permeability
07/14/1999EP0928293A1 Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity
07/14/1999CN1222916A Method for producing peptides
07/13/1999US5922838 Antitumor agents
07/13/1999US5922580 Contacting a reducing partial starch hydrolysate with a novel enzyme which forms a non-reducing saccharide in the absence of trehalose; glucoamylase and glycosidase yield trehalose when allowed to act on the non-reducing saccharide
07/13/1999US5922532 Synthetic antigens for the detection of antibodies to hepatitis C virus
07/13/1999US5922303 Technetium-99M labeled peptides for imaging
07/13/1999CA1340646C Cyclic anticoagulant peptides
07/08/1999WO1999033969A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine
07/08/1999WO1999033875A1 Compounds and methods for modulating synaptic stability
07/08/1999WO1999033865A1 Contryphan peptides
07/08/1999WO1999033863A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
07/08/1999WO1999014231A3 Bifidus stimulating peptides and its uses
07/08/1999CA2317029A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine
07/07/1999EP0927723A1 Bicyclic depsipeptides promoting the production of apolipoprotein E
07/07/1999EP0926955A1 Conjugates useful in the treatment of prostate cancer
07/07/1999EP0661985B1 Peptides capable of binding cd8 molecules on ctl precursors
07/07/1999EP0587799B1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
07/07/1999EP0585412B1 Increasing blood-brain barrier permeability with permeabilizer peptides
07/07/1999CN1222161A Process for preparing certain aza cyclohexapeptides
07/07/1999CN1222082A Compsns. comprising antifungal agent and acetate buffer
07/07/1999CN1221752A Novel lantibiotic related to actagardine, and process for preparation and use thereof
07/06/1999US5919764 Detecting tumor having p185 on cell surfaces by administering peptide and detecting localized peptide in body of patient
07/06/1999US5919756 Amides
07/06/1999US5919639 Ii peptide therapeutics to enhance antigen presentation
07/06/1999US5919634 Immunoassay using antibody or fragment which preferentially binds to crosslinked telopeptide with lysylpyridinoline or hydroxylysylpyridinoline residues; for diagnosis of osteoarthritis/rheumatoid arthritis; monitoring of treatment
07/06/1999CA2233593A1 Novel protein molecules and uses therefor
07/06/1999CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto
07/06/1999CA1340636C Dermorphin analogs, their methods of preparation, pharmaceutical compositions and methods of therapeutic treatment using the same
07/01/1999WO1999032513A1 Protein binding polypeptides
07/01/1999WO1999032512A1 Novel method for preparing cylosporin derivatives
07/01/1999WO1999012962A8 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
07/01/1999CA2315301A1 Protein binding polypeptides
06/1999
06/30/1999EP0925308A2 Compositions and methods for treating infections using analogues of indolicidin
06/30/1999CN1221424A 肽衍生物 Peptide derivatives
06/30/1999CN1221345A Isolated necleic acid molecules which code for GAGE tumor rejection antigen, the tumor rejection antigen, and uses thereof
06/29/1999US5917670 In a hard disk drive
06/29/1999US5917012 Peptide derivatives